Physician profile
Barton Harris
NPI 1265649164
$741,415.42
in general payments reported to CMS, 2019-2025
10 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104K · 2020: $20K · 2021: $12K · 2022: $528K · 2023: $50K · 2024: $8,519 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $59K · Consulting Fee: $16K · Food and Beverage: $1,967 · Travel and Lodging: $11.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $58,534.07 |
| Consulting Fee | $16,280.00 |
| Food and Beverage | $1,967.41 |
| Travel and Lodging | $11.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $583,223.72 | 2022-2025 | Engage Partial Knee System |
| Exactech, INC. | $154,540.18 | 2019-2024 | |
| Depuy Synthes Products, INC. | $1,625.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $1,239.90 | 2021-2025 | Persona, Rosa, Oss Orthopedic Salvage System |
| Engage Uni, LLC | $258.13 | 2020-2021 | |
| Stryker Corporation | $193.27 | 2023 | Mako, Triathlon, Tritanium |
| Advita Ortho, LLC | $139.39 | 2025 | |
| Depuy Synthes Sales INC. | $111.49 | 2022-2025 | Monovisc |
| Ethicon US, LLC | $54.89 | 2021-2023 | Dermabond, Monocryl, Stratafix |
| Innovation Technologies INC | $29.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$695,319.54 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.